SCAI publishes recommendations
for prevention of contrast-induced nephropathy (from theheart.org)
Springfield, MA - The Society
of Cardiovascular Angiography and Interventions (SCAI) has published
recommendations to assist in the prevention of contrast-induced nephropathy
(CIN). In addition to the routine use of the estimated glomerular filtration
rate (eGFR) to identify patient risk for CIN, recommendations include
vigorous volume repletion, limiting contrast volume, and the use of low- or
iso-osmolar contrast media. "The risk of CIN varies
from 2% to 3% in unselected patients undergoing cardiovascular angiographic
procedures," writes lead author Dr Marc Schweiger (Baystate
Medical Center, Springfield, MA) and colleagues in the consensus statement,
published in the January 2007 issue of Catheterization and Cardiovascular
Interventions. "It is associated with a significant increase in
patient morbidity and mortality. Recognition of the high-risk patient coupled
with appropriate periprocedural management can reduce the incidence of
CIN."
|